RVII
RVIICIK 0002131040
No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (CALM 10-Q) is open in full — no account needed.
Summary not yet generated.
RVII prices IPO of 8M shares at $25, raising $185.1M net for YC-focused BDC advised by Robinhood unit
5 material changes detected. Sign up free to read the summary.
Partner
Trade RVII commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Latest financial statements
From 10-Q filed Sep 28, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Statement of Operations (Unaudited)
| Description | Three months ended June 30, 2026 (a) |
|---|---|
| Expenses: | |
| Organizational expenses (b) | 1,191,516 |
| Professional fees | 96,771 |
| Sub-administrator and custody expenses | 35,850 |
| Trustees’ fees | 30,937 |
| Other general and administrative expenses | 29,090 |
| Total expenses before cost support and reimbursement | 1,384,164 |
| Organizational costs support and reimbursement (b) | (1,603,347) |
| Total expenses after cost support and reimbursement | (219,183) |
| Net investment income | 219,183 |
| Net realized gain and change in unrealized appreciation: | |
| Net realized and unrealized gain on investments | — |
| Net increase in net assets from operations | 219,183 |
Statements of Assets and Liabilities
| Description | June 30, 2026 (Unaudited) | March 31, 2026 |
|---|---|---|
| Assets: | ||
| Investments at fair value (cost of $19,600,000 and $8,850,000, respectively) | 19,600,000 | 8,850,000 |
| Cash | 2,996,280 | 5,750,000 |
| Deferred offering costs | 1,615,769 | 259,494 |
| Due from Affiliate (a) | 1,603,347 | — |
| Total assets | 25,815,396 | 14,859,494 |
| Liabilities: | ||
| Accrued expenses | 155,536 | 19,830 |
| Accrued organizational expenses (a) | 1,603,347 | 411,831 |
| Accrued offering costs | 1,518,981 | 259,494 |
| Payable for investments purchased | 250,000 | 2,100,000 |
| Total liabilities | 3,527,864 | 2,791,155 |
| Commitments and contingencies (Note 8) | ||
| Net Assets | 22,287,532 | 12,068,339 |
| Net Assets consist of: | ||
| Paid-in capital | 22,500,010 | 12,500,000 |
| Total distributable losses | (212,478) | (431,661) |
| Net Assets | 22,287,532 | 12,068,339 |
| Net asset value per share: (b) | ||
| Shares outstanding (c) | 930,583 | 488,290 |
| Net asset value per share | 23.95 | 24.72 |
Statement of Cash Flows (Unaudited)
| Description | Three months ended June 30, 2026 (a) |
|---|---|
| Cash flows from operating activities: | |
| Net increase in net assets from operations | 219,183 |
| Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities: | |
| Purchases of investments | (12,600,000) |
| Accrued expenses | 135,706 |
| Deferred offering costs | (96,788) |
| Accrued organizational expenses | 1,191,516 |
| Due from Affiliate | (1,603,347) |
| Net cash used in operating activities | (12,753,730) |
| Cash flows from financing activities: | |
| Proceeds from issuance of shares | 10,000,010 |
| Net cash provided by financing activities | 10,000,010 |
| Net decrease in cash | (2,753,720) |
| Cash, beginning of period | 5,750,000 |
| Cash, end of period | 2,996,280 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗